CITR
CitroTech Inc.
There isn't enough reported data to score CITR yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
CITR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
CITR's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CITR.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
CITR PE Valuation
CITR has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
CITR Forward outlook
There aren't enough analyst estimates for CITR to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
CITR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$0.62 | -$0.46 |
| Q2 2023 | -$0.08 | +$0.08 |
| Q1 2023 | -$0.23 | -$0.22 |
| Q4 2022 | -$0.24 | -$0.24 |
| Q1 2010 | -$4.02 | -$0.48 |
MS has the stronger earnings trend. Trailing diluted EPS is down 679% for CITR versus MS up 29%.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
CITR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $664.3K | +130% |
| Q2 2026 | $280.7K | -59% |
| Q1 2026 | $344.9K | -64% |
| Q4 2025 | $436.2K | +526% |
| Q3 2025 | $288.2K | +169% |
| Q2 2025 | $687.6K | +246% |
| Q1 2025 | $969.4K | +124% |
| Q4 2024 | $69.6K | -73% |
CITR's revenue is recovering but still below its 2009 peak: $664,328 last quarter, up 130% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -344% | +1126 points |
| Q2 2026 | -1245% | -806 points |
| Q1 2026 | -1289% | -933 points |
| Q4 2025 | -1326% | +397 points |
| Q3 2025 | -1470% | -946 points |
| Q2 2025 | -439% | +18 points |
| Q1 2025 | -357% | +252 points |
| Q4 2024 | -1722% | -1582 points |
CITR's operating margin was −344% last quarter, up 1126 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over CITR on profitability, with a higher operating margin.
CITR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$103.4K |
| Q2 2026 | -$1.8M | -$431K |
| Q1 2026 | -$2.1M | -$1.3M |
| Q4 2025 | -$2.5M | -$1.8M |
| Q2 2025 | -$1.4M | -$927.5K |
| Q1 2025 | -$740.9K | -$397.2K |
| Q4 2024 | -$617.8K | -$224.2K |
| Q1 2024 | -$343.7K | -$166.8K |
CITR's free cash flow was −$8M over the past year, against −$4M the year before. Free cash flow isn't a meaningful measure for financial services companies like CITR.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the edge over CITR on cash flow, with more consistent year-over-year improvement.
CITR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +421K shares |
| 1 year | +112% | +11.7M shares |
| 3 years | +77% | +9.6M shares |
| 5 years | +784% | +19.7M shares |
CITR has 22M diluted shares, up 112% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2010 | — |
| Q4 2009 | — |
| Q3 2009 | — |
| Q2 2009 | — |
| Q1 2009 | — |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over CITR on shareholder dilution, with a more favorable share count trend.
CITR Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
CITR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.3 | Neutral |
| Stochastic | 6.2 | Oversold |
CITR's weekly RSI is 31 (neutral) and its Stochastic is 6 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
CITR PE vs Financial Services Sector
CITR has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
CITR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.88 | 17% below |
| 20 week MA | $4.52 | 47% below |
| 50 week MA | $6.33 | 62% below |
MS has stronger trend alignment. CITR is above 0 of 3 weekly averages versus MS above 3 of 5.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
CITR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $7.12 | $8.51 | +20% |
| 2026 YTD | $8.51 | $2.39 | -72% |
CITR has finished every year since 2025 higher, and it's down 72% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over CITR on returns for 2026, with the stronger performance.